Aclaris Therapeutics, Inc.
Ticker: ACRS
| Insider | Title |
|---|---|
| Anand Mehra | Director |
| Andrew Kenneth William Powell | Director |
| Andrew N Schiff | Director |
| Braden Michael Leonard | 10% or greater ownership |
| Bryan M. Reasons | Director |
| Capital Fund Iii, L.p. Foresite | 10% or greater ownership |
| Capital Fund Iv, L.p. Foresite | 10% or greater ownership |
| Capital Fund V, L.p. Foresite | 10% or greater ownership |
| Capital Management Iii, Llc Foresite | 10% or greater ownership |
| Capital Management Iv, Llc Foresite | 10% or greater ownership |
| Capital Management V, Llc Foresite | 10% or greater ownership |
| Christopher P. Molineaux | Director |
| David N. Gordon | Chief Medical Officer |
| Douglas J. Manion | Pres and CEO, Director |
| Frank Ruffo | Chief Financial Officer |
| Gail Cawkwell | Chief Medical Officer |
| Hugh M. Davis | President and COO, Director |
| James B. Tananbaum | Director, 10% or greater ownership |
| James Loerop | Chief Business Officer |
| Joseph Monahan | Chief Scientific Officer |
| Kamil Ali-jackson | Chief Legal Officer |
| Kevin Balthaser | Chief Financial Officer |
| Maxine Gowen | Director |
| Neal Walker | INTERIM PRESIDENT AND CEO, Director |
| Vincent Milano | Director |
| William D. Humphries | Director |